デフォルト表紙
市場調査レポート
商品コード
1631523

椎体形成術および肝動脈形成術用針の市場規模、シェア、動向分析レポート:手技別、最終用途別、地域別、セグメント別予測、2025年~2030年

Vertebroplasty And Kyphoplasty Needles Market Size, Share & Trends Analysis Report By Procedure (Kyphoplasty Procedures), By End Use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 100 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
椎体形成術および肝動脈形成術用針の市場規模、シェア、動向分析レポート:手技別、最終用途別、地域別、セグメント別予測、2025年~2030年
出版日: 2024年12月13日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

椎体形成術および肝動脈形成術用針市場の成長と動向

椎体形成術および肝動脈形成術用針の世界市場規模は、2030年には12億1,020万米ドルに達すると予測され、予測期間のCAGRは4.9%で成長すると予測されています。

椎骨障害になりやすい高齢者の増加と、それに伴うリスクが少ないことによる低侵襲手技の需要が市場成長を後押ししています。

冒険、スポーツ、事故に関連する傷害の発生率の増加も市場成長を押し上げると予測されています。2018年の「Database of the National Spinal Cord Injury」によると、米国では脊髄損傷の新規症例の6.0%が報告されており、そのうち38.0%が自動車事故によるもの、8.0%がスポーツによるものでした。

椎体圧迫骨折の有病率は年齢とともに増加し、骨粗鬆症の最も一般的な後遺症の一つです。米国では毎年約750万0,000件の椎体圧迫骨折が新たに発生しており、その結果、椎体骨折患者の3分の1以上に慢性疼痛や急性疼痛が発生しています。

椎体圧迫骨折の患者は、一般に激しい背部痛を経験し、そのために運動が制限されることがあります。椎体形成術とバルーン形成術は、椎体の高さと強度を回復させることに成功し、患者の痛みを軽減できることが証明されています。これらの手術は低侵襲であり、大規模な開腹脊椎固定術と比較してリスクが低いため、高い需要があります。

米国骨代謝学会は、椎体形成術とその他の椎体圧迫骨折の治療法の安全性と有効性に関して、両医療処置の安全性と有効性に関する同意が得られていないため、タスクフォースを設立して取り組んでいます。

椎体形成術および肝動脈形成術用針市場レポートハイライト

  • 2024年の最大シェアは60.4%。骨盤形成術は椎体形成術の進化版であり、変形を減らし、高さを回復し、骨折を安定させることができ、他の手技よりも3倍多く実施されています。
  • 最終用途別では、外来手術センターセグメントが、近代的な医療施設に対する需要の増加により、最も速い成長を記録すると予測されています。
  • 病院セグメントは2024年に59.7%のシェアを占め、市場を独占しています。脊椎疾患、特に骨粗鬆症の有病率の増加が、病院における椎体形成術と骨形成術の需要を牽引しています。
  • 北米の椎体形成術および肝動脈形成術用針市場は、2024年に39.4%の最大シェアを占めました。これは、低侵襲処置に対する需要の高まりと、椎体形成術の治療用デバイスを提供する多数の参入企業の存在によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 椎体形成術および肝動脈形成術用針市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 椎体形成術および肝動脈形成術用針市場:手技ビジネス分析

  • 手技市場シェア、2024年と2030年
  • 手技セグメントダッシュボード
  • 市場規模と予測と動向分析、手技別、2018~2030年
  • 椎体形成術の手順
  • 椎体形成術の手順

第5章 椎体形成術および肝動脈形成術用針市場:最終用途ビジネス分析

  • 最終用途市場シェア、2024年と2030年
  • 最終用途セグメントダッシュボード
  • 市場規模と予測と動向分析、最終用途別、2018~2030年
  • 病院
  • 外来手術センター

第6章 椎体形成術および肝動脈形成術用針市場:手技と最終用途による地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模と予測動向分析、2018~2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Stryker
    • Medtronic
    • IZI Medical Products
    • Globus Medical
    • BPB medica-Biopsybell
    • Teknimed
    • Merit Medical Systems
    • ZAVATION
    • RONTIS
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global vertebroplasty and kyphoplasty needles market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 5. Global vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 6. North America vertebroplasty and kyphoplasty needles market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 8. North America vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 9. U.S. vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 10. U.S. vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 11. Canada vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 12. Canada vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 13. Mexico vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 14. Mexico vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 15. Europe vertebroplasty and kyphoplasty needles market, by country, 2018 - 2030 (USD Million)
  • Table 16. Europe vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 17. Europe vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 18. UK vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 19. UK vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 20. Germany vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 21. Germany vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 22. France vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 23. France vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 24. Italy vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 25. Italy vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 26. Spain vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 27. Spain vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 28. Denmark vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 29. Denmark vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 30. Sweden vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 31. Sweden vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 32. Norway vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 33. Norway vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific vertebroplasty and kyphoplasty needles market, by country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 37. Japan vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 38. Japan vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 39. China vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 40. China vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 41. India vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 42. India vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 43. Australia vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 44. Australia vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 45. South Korea vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 46. South Korea vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 47. Thailand vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 48. Thailand vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 49. Latin America vertebroplasty and kyphoplasty needles market, by country, 2018 - 2030 (USD Million)
  • Table 50. Latin America vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 51. Latin America vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 52. Brazil vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 53. Brazil vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 54. Argentina vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 55. Argentina vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa vertebroplasty and kyphoplasty needles market, by country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 59. South Africa vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 60. South Africa vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 63. UAE vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 64. UAE vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait vertebroplasty and kyphoplasty needles market, by procedure, 2018 - 2030 (USD Million)
  • Table 66. Kuwait vertebroplasty and kyphoplasty needles market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Vertebroplasty and kyphoplasty needles market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product design and product outlook (USD Million)
  • Fig. 10 Application outlook
  • Fig. 11 Competitive landscape
  • Fig. 12 Vertebroplasty and kyphoplasty needles market dynamics
  • Fig. 13 Vertebroplasty and kyphoplasty needles market: Porter's five forces analysis
  • Fig. 14 Vertebroplasty and kyphoplasty needles market: PESTLE analysis
  • Fig. 15 Vertebroplasty and kyphoplasty needles market: Procedure segment dashboard
  • Fig. 16 Vertebroplasty and kyphoplasty needles market: Procedure market share analysis, 2024 & 2030
  • Fig. 17 Kyphoplasty procedures market, 2018 - 2030 (USD Million)
  • Fig. 18 Vertebroplasty procedures market, 2018 - 2030 (USD Million)
  • Fig. 19 Vertebroplasty and kyphoplasty needles market: End Use segment dashboard
  • Fig. 20 Vertebroplasty and kyphoplasty needles market: End Use market share analysis, 2024 & 2030
  • Fig. 21 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 22 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 23 Vertebroplasty and kyphoplasty needles market revenue, by region
  • Fig. 24 Regional marketplace: Key takeaways
  • Fig. 25 Regional marketplace: Key takeaways
  • Fig. 26 North America vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. country dynamics
  • Fig. 28 U.S. vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 29 Canada country dynamics
  • Fig. 30 Canada vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico country dynamics
  • Fig. 32 Mexico vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 34 UK country dynamics
  • Fig. 35 UK vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany country dynamics
  • Fig. 37 Germany vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 38 France country dynamics
  • Fig. 39 France vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy country dynamics
  • Fig. 41 Italy vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain country dynamics
  • Fig. 43 Spain vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark country dynamics
  • Fig. 45 Denmark vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden country dynamics
  • Fig. 47 Sweden vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway country dynamics
  • Fig. 49 Norway vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan country dynamics
  • Fig. 52 Japan vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 53 China country dynamics
  • Fig. 54 China vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 55 India country dynamics
  • Fig. 56 India vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia country dynamics
  • Fig. 58 Australia vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea country dynamics
  • Fig. 60 South Korea vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand country dynamics
  • Fig. 62 Thailand vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil country dynamics
  • Fig. 65 Brazil vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina country dynamics
  • Fig. 67 Argentina vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 68 MEA vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa country dynamics
  • Fig. 70 South Africa vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia country dynamics
  • Fig. 72 Saudi Arabia vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 73 UAE country dynamics
  • Fig. 74 UAE vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 75 Kuwait Key country dynamics
  • Fig. 76 Kuwait vertebroplasty and kyphoplasty needles market, 2018 - 2030 (USD Million)
  • Fig. 77 Company categorization
  • Fig 78 Company market position analysis
  • Fig. 79 Strategic framework
目次
Product Code: GVR-4-68038-644-8

Vertebroplasty And Kyphoplasty Needles Market Growth & Trends:

The global vertebroplasty and kyphoplasty needles market size is expected to reach USD 1,210.2 million in 2030 and is anticipated to grow at a CAGR of 4.9% over the forecast period. Increasing geriatric population prone to vertebral disorders and demand for minimally invasive procedures due to the fewer risks associated with them is boosting market growth.

Increase in incidence rates of injuries associated with adventure, sports, and accidents are also anticipated to boost market growth. As per the 2018, Database of the National Spinal Cord Injury, round 6.0% of new cases of spinal cord injury were reported in U.S. of which 38.0% were due to vehicle accidents and 8.0% due to sports injury.

The prevalence of vertebral compression fractures increases with age and is one of the most common sequelae of osteoporosis. There are around 7,50,000 new vertebral compression fractures every year in U.S. with resultant chronic and acute pain in over one-third of the patients with vertebral fractures.

Patients with VCFs generally experience severe back pain that may limit mobility. The vertebroplasty and balloon kyphoplasty procedures have been proven successful in restoring vertebral height and strength and are capable of reducing pain in patients. There is a high demand for the procedures as they are minimally invasive and possess low risks as compared to the larger open spinal fusion surgery.

The American Society for Bone and Mineral Research has established a Task Force to address the safety and efficacy of vertebral augmentation and other methods to treat the vertebral compression fractures as there is a lack of consent regarding the safety and efficacy of both medical procedures.

Vertebroplasty And Kyphoplasty Needles Market Report Highlights:

  • The kyphoplasty procedures segment accounted for the largest share of 60.4% in 2024. Kyphoplasty is the advanced version of vertebroplasty and can reduce deformities, restore heights, and stabilize fractures and are three times more commonly performed than the other procedure
  • Based on end-use, the ambulatory surgical center segment is anticipated to register the fastest growth due to the increasing demand for modern healthcare facilities
  • The hospitals segment dominated the market with a share of 59.7% in 2024. The increasing prevalence of spinal disorders, particularly osteoporosis, is driving demand for vertebroplasty and kyphoplasty in hospitals.
  • North America vertebroplasty and kyphoplasty needles market held the largest share of 39.4% in 2024. This is due to the rising demand for minimally invasive procedures as well as the presence of the large number of players that cater to the devices for the treatment of VCF.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Procedure
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Vertebroplasty and Kyphoplasty Needles Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Vertebroplasty and Kyphoplasty Needles Market: Procedure Business Analysis

  • 4.1. Procedure Market Share, 2024 & 2030
  • 4.2. Procedure Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
  • 4.4. Kyphoplasty Procedures
    • 4.4.1. Kyphoplasty procedures market, 2018 - 2030 (USD Million)
  • 4.5. Vertebroplasty Procedures
    • 4.5.1. Vertebroplasty procedures market, 2018 - 2030 (USD Million)
    • 4.5.2. Directional Vertebroplasty Needles
      • 4.5.2.1. Directional vertebroplasty needles market, 2018 - 2030 (USD Million)
    • 4.5.3. Straight Vertebroplasty Needles
      • 4.5.3.1. Straight vertebroplasty needles market, 2018 - 2030 (USD Million)

Chapter 5. Vertebroplasty and Kyphoplasty Needles Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market, 2018 - 2030 (USD Million)
  • 5.5. Ambulatory Surgical Centers
    • 5.5.1. Ambulatory surgical centers market, 2018 - 2030 (USD Million)

Chapter 6. Vertebroplasty and Kyphoplasty Needles Market: Regional Estimates & Trend Analysis by Procedure and End Use

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key country dynamic
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive insights
      • 6.4.2.4. U.S. vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key country dynamic
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive insights
      • 6.4.3.4. Canada vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key country dynamic
      • 6.4.4.2. Regulatory framework
      • 6.4.4.3. Competitive insights
      • 6.4.4.4. Mexico vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key country dynamic
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive insights
      • 6.5.2.4. UK vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key country dynamic
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive insights
      • 6.5.3.4. Germany vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key country dynamic
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive insights
      • 6.5.4.4. France vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key country dynamic
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive insights
      • 6.5.5.4. Italy vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key country dynamic
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive insights
      • 6.5.6.4. Spain vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key country dynamic
      • 6.5.7.2. Regulatory framework
      • 6.5.7.3. Competitive insights
      • 6.5.7.4. Denmark vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key country dynamic
      • 6.5.8.2. Regulatory framework
      • 6.5.8.3. Competitive insights
      • 6.5.8.4. Sweden vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key country dynamic
      • 6.5.9.2. Regulatory framework
      • 6.5.9.3. Competitive insights
      • 6.5.9.4. Norway vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamic
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive insights
      • 6.6.2.4. Japan vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key country dynamic
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive insights
      • 6.6.3.4. China vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key country dynamic
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive insights
      • 6.6.4.4. India vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key country dynamic
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive insights
      • 6.6.5.4. Australia vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key country dynamic
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive insights
      • 6.6.6.4. South Korea vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key country dynamic
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive insights
      • 6.6.7.4. Thailand vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key country dynamic
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive insights
      • 6.7.2.4. Brazil vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key country dynamic
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive insights
      • 6.7.3.4. Argentina vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key country dynamic
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive insights
      • 6.8.2.4. South Africa vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key country dynamic
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive insights
      • 6.8.3.4. Saudi Arabia vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key country dynamic
      • 6.8.4.2. Regulatory framework
      • 6.8.4.3. Competitive insights
      • 6.8.4.4. UAE vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key country dynamic
      • 6.8.5.2. Regulatory framework
      • 6.8.5.3. Competitive insights
      • 6.8.5.4. Kuwait vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Stryker
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. Medtronic
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. IZI Medical Products
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Globus Medical
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. BPB medica - Biopsybell
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Teknimed
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Merit Medical Systems
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. ZAVATION
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. RONTIS
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product benchmarking
      • 7.5.9.4. Strategic initiatives